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Mammalian circadian oscillators are considered to rely on
transcription/translation feedback loops in clock gene
expression. The major and essential loop involves the autore-
pression of cryptochrome (Cry1, Cry2) and period (Per1, Per2)
genes. The rhythm-generating circuitry is functional in most
cell types, including cultured fibroblasts. Using this system,
we show that significant reduction in RNA polymerase II-
dependent transcription did not abolish circadian oscilla-
tions, but surprisingly accelerated them. A similar period
shortening was observed at reduced incubation temperatures
in wild-type mouse fibroblasts, but not in cells lacking Per1.
Our data suggest that mammalian circadian oscillators are
resilient to large fluctuations in general transcription rates
and temperature, and that PER1 has an important function in
transcription and temperature compensation.
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Introduction
The mammalian circadian timing system has a hierarchical
structure, in that a master pacemaker residing in the
suprachiasmatic nucleus synchronizes slave oscillators exist-
ing in most body cells (Takahashi, 2004; Reppert, 2006). Cell-
autonomous and self-sustained clocks were also found
in cultured cells (Balsalobre et al, 1998; Nagoshi et al,
2004; Liu et al, 2007).
In 1990, Rosbash and co-workers (Hardin et al, 1990)
discovered that the Drosophila clock protein Period (PER)
inhibits the transcription of its own gene, and hence proposed
a negative transcription/translation feedback loop as the
operational principle for rhythm generation. Since then a
large number of circadian clock genes have been identified
in a variety of organisms from cyanobacteria to humans, and
negative feedback loops are still the prevalent model for most
of these organisms (Lakin-Thomas, 2006; Gallego and
Virshup, 2007). In mammals, the CLOCK and BMAL1 tran-
scription factors activate the expression of Per and Cry genes.
Once PER and CRY concentrations have reached a critical
threshold, they attenuate the CLOCK/BMAL1-mediated acti-
vation of their own genes in a negative feedback loop
(Hastings and Herzog, 2004; Reppert, 2006). However,
posttranslational events, such as the control of protein
phosphorylation, acetylation, degradation, sumoylation and
nucleocytoplasmic shuttling, contribute critically to the
circadian rhythm generation and may affect period length,
amplitude and/or magnitude of the oscillations (Lee et al,
2001; Cardone et al, 2005; Asher et al, 2008).
Although most physiological processes run faster at higher
temperature, the period length of circadian oscillators re-
mains nearly constant over a wide range of physiological
temperatures (Konopka et al, 1989; Kaushik et al, 2007;
Takeuchi et al, 2007). This even applies to circadian oscilla-
tors of homoeotherm organisms, such as those operative in
cultured mammalian fibroblasts (Izumo et al, 2003; Tsuchiya
et al, 2003). Here, we show that circadian clocks of fibro-
blasts are also compensated for global transcription rates.
Considering that intrinsic transcription rates vary signifi-
cantly in cells from different tissues (Schmidt and Schibler,
1995), transcription compensation may be an important
property of peripheral circadian clocks.
Results
Long-term inhibition of RNA polymerase II-dependent
transcription
Global transcription rates can be attenuated by the exposure
of cells to various drugs that function at different steps. The
most widely used compounds are actinomycin D and
a-amanitin. Actinomycin D intercalates into double-stranded
DNA and blocks transcription elongation by all three poly-
merases, RNA polymerase I (Pol I) being particularly sensi-
tive. a-Amanitin is a selective and specific inhibitor of RNA
polymerase II (Pol II) and RNA polymerase III (Pol III) in vitro
and in vivo, with Pol II being considerably more sensitive
than Pol III. a-Amanitin binds to RPB1, the largest Pol II
subunit, with high affinity and thereby prevents translocation
by blocking Pol II bridge helix bending (Bushnell et al, 2002).
In addition, this drug induces the ubiquitination of the
C-terminal domain of RPB1 and elicits proteasome-mediated
RPB1 degradation in a dose-dependent manner (Nguyen et al,
1996; Mitsui and Sharp, 1999; Arima et al, 2005).
To examine the impact of overall transcription rates on
circadian oscillator function, we analysed circadian gene
expression in a-amanitin- and actinomycin D-treated
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fibroblasts. To this end, we had to identify conditions that
allowed the recording of gene expression for extended time
periods. Long-term treatment with a-amanitin and actinomy-
cin D at concentrations higher than 0.5 mg/ml and 10 nM,
respectively, caused significant cell death (Supplementary
Figure 1A and B). However, the pretreatment of cells with
sublethal doses of a-amanitin and actinomycin D for 16 and
5 h, respectively, allowed the recording of circadian biolumi-
nescence during at least 3 days at reduced transcription rates
(see Figure 1A for experimental design).
To validate this approach, we estimated the inhibitory
effects of a-amanitin and actinomycin D on Pol II-dependent
transcription by several methods (Figure 1B–E) and assayed
transcription rates or RPB1 expression during 48–72 h after
the drugs were washed away. First, in vivo transcription
rates in NIH3T3 cells pretreated for 16 h with a-amanitin
(3–5 mg/ml) or in untreated cells were measured by the
incorporation of [3H]uridine after labelling the cells for
60 min (Figure 1B). In keeping with previous publications
(Adolph et al, 1993), we found that pretreatment of NIH3T3
cells with 3 and 5 mg/ml of a-amanitin for 16 h reduced RNA
synthesis to about 60 and 35%, respectively, when compared
with untreated cells (Figure 1B, panel 0 h). The inhibitory
effect of a-amanitin on overall transcription rates persisted
for at least 48 h (Figure 1B). In the second approach, in vitro
incorporation of [32P]UTP (uridine triphosphate) was
measured in isolated cell nuclei by run-on transcription
assays under conditions favouring efficient elongation
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Figure 1 Reduction of RNA polymerase II-mediated transcription by sublethal concentrations of a-amanitin and actinomycin D.
(A) Experimental design scheme. (B) [14C]Thymidine-prelabeled NIH3T3 cells were treated for 16 h with 0–5mg/ml of a-amanitin and
pulse-labeled with [3H]uridine for 60 min at the indicated time points. Transcription rates were calculated on a per DNA basis as described in
Materials and methods. Pretreatment of NIH3T3 cells with 3 mg/ml of a-amanitin for 16 h reduced RNA synthesis to 58±13% relative to
untreated control (n¼ 5); with 5mg/ml of a-amanitin to 36±6% (n¼ 4; panel 0 h). At 24 h after a-amanitin removal, the relative transcription
rates amounted to 42±14% (n¼ 5) and 26±6% (n¼ 4), respectively, for the two drug concentrations (panel 24 h), and 48 h after drug
removal, they amounted to 81±24% (n¼ 5) and 29±5% (n¼ 4; panel 48 h), respectively. (C) Relative run-on transcription rates were
determined for nuclei of NIH3T3 fibroblasts pretreated with 3mg/ml of a-amanitin for 16 h or with 50 nM actinomycin D for 5 h. (D) Expression
profiles of c-fos precursor RNA from untreated cells and cells pretreated with 3mg/ml a-amanitin during 16 h. Cells were collected at the
indicated time points after horse serum addition (time 0); transcripts were quantified as described in Materials and methods. (E) Western blot
analysis of whole-cell extracts from untreated cells and cells pretreated with 3mg/ml a-amanitin. The antibodies used recognize the RPB1 and
the splicing factor U2AF65 (loading control).
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predominantly by Pol II (Gariglio et al, 1981; Schmidt and
Schibler, 1995). Pretreatment with a-amanitin (3mg/ml) abol-
ished about 85% of Pol II-dependent transcription immediately
after drug elimination, and about 70% after 72 h
(Figure 1C). Actinomycin D (50 nM) inhibited about half of
Pol II-dependent transcription immediately after drug re-
moval, with partial recovery to 73% after 72 h (Figure 1C).
We noticed that the incorporation rate of uridine into RNA in
a-amanitin-pretreated cells (Figure 1 B) was somewhat high-
er after 48 h than expected on the basis of the in vitro run-on
experiments performed with cells analysed 72 h after the
pretreatment (Figure 1C). This may have been caused by a
reduction of the nuclear UTP pool size, which is difficult to
measure experimentally.
Next, we determined the effect of a-amanitin on the
induction of c-fos precursor RNA by a serum shock (Adolph
et al, 1993) and found that this immediate early response was
significantly dampened in drug-treated cells (Figure 1D).
Finally, we evaluated a-amanitin-mediated RPB1 degrada-
tion. As shown in Figure 1E, a western blot analysis revealed
a strong reduction in RPB1 protein levels after a 16-h treat-
ment of cells with 3 mg/ml a-amanitin, and RPB1 accumula-
tion remained low for at least 48 h (Figure 1E).
Inhibition of clock gene transcription by a-amanitin
To determine the impact of a-amanitin treatment on the
transcription of core clock genes, mRNA accumulation pat-
terns for synchronized NIH3T3 cells were monitored by
quantitative RT–PCR using amplicons for Bmal1, Rev-erba,
Dbp, Per1 and Per2. The values thus obtained were then
normalized to Q-PCR values measured for a Gapdh amplicon
in genomic DNA from duplicate plates, to express transcript
accumulation levels in cellular equivalents (see Materials and
methods). As shown in Figure 2, the a-amanitin treatment
inhibited the cellular accumulation of transcripts specified by
all examined core clock and clock-controlled genes, albeit to
somewhat different extents. Genes such as Per1, Per2 and
Dbp, the transcription of which is activated by BMAL1-
CLOCK and repressed by PER–CRY complexes, were particu-
larly sensitive to a-amanitin treatment. In addition, the
serum-induced immediate early induction of Per1 and Per2
expression was strongly blunted in drug-treated cells
(Figure 2). Although these experiments suggested that
NIH3T3 clocks still function in a-amanitin-treated cells, the
low magnitude, amplitude and temporal resolution observed
in the temporal mRNA accumulation profiles did not allow
for a more detailed characterization of circadian phenotypes
caused by the reduction of global transcription rates. Hence,
we resorted to more sensitive reporter gene assays with a
high temporal resolution power.
Circadian gene expression is resilient to large
fluctuations in transcription rates
Fibroblasts expressing fire fly luciferase from circadian pro-
moters exhibit robust circadian bioluminescence rhythms in
synchronized cell populations and individual cells (Nagoshi
et al, 2004; Liu et al, 2007). To assess the impact of reduced
transcription on circadian gene expression, we monitored
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Figure 2 Endogenous core clock genes oscillate with a lower circadian amplitude at reduced Pol II-dependent transcription rates. Expression
profiles of Bmal1, Rev-erba, Dbp, Per1 and Per2 mRNA from untreated cells and cells pretreated with 3mg/ml a-amanitin for 16 h. The cells were
collected at the indicated time points after the addition of horse serum (time 0). The relative mRNA levels were determined by qRT–PCR
analysis and normalized to genomic DNA (see Materials and methods).
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circadian bioluminescence of synchronized NIH3T3 fibroblasts
stably expressing luciferase driven from Bmal1 promoter
(Nagoshi et al, 2004) after a 16-h pretreatment with sublethal
concentrations of a-amanitin and actinomycin D. As shown in
Figure 3A, robust bioluminescence cycles could be detected in
cells pretreated with 1–3mg/ml of a-amanitin, and residual
oscillation was observed in experiments with 5 mg/ml. As
expected, the magnitude of Bmal1-luc expression progres-
sively decreased with increasing a-amanitin concentrations
(Figure 3A, right panel). Unexpectedly, however, period
length gradually shortened with decreasing overall transcrip-
tion rates (Figure 3A, middle panel). Thus, cells pretreated
with 3mg/ml a-amanitin oscillated with a 2.3-h shorter period
than untreated cells. Actinomycin D pretreatment had similar
effects on the bioluminescence cycles generated by Bmal1-luc
cells (Figure 3B, left panel). Similar to a-amanitin, actinomy-
cin D reduced the magnitude, amplitude and period length of
circadian Bmal1-luc expression (Figure 3B). Pretreatment
with a-amanitin and actinomycin D also caused a shortening
of the period length and a dampening of amplitude and
magnitude of bioluminescence cycles produced by skin tail
fibroblasts from mPer2Hluciferase mice (Supplementary
Figure 2A and B). a-Amanitin had a similar effect
on NIH3T3 cells expressing luciferase from Dbp regulatory
sequence oscillation pattern (Supplementary Figure 2C).
As shown in Supplementary Figure 3, a-amanitin affected
circadian gene expression to a similar extent in cells synchro-
nized by a short incubation with dexamethasone, horse
serum or glucose (Balsalobre et al, 2000; Hirota et al,
2002). Thus, the alterations in circadian gene expression
caused by transcription-inhibiting drugs depend neither on
the signalling pathways used for the synchronization of cells
nor on the expressed circadian reporter genes.
Individual fibroblast clocks exhibit robust oscillations
in cells with reduced global transcription rates
At the population level, Bmal1-1uc cells exhibited progres-
sively lower amplitude and magnitude oscillations as tran-
scription rates dropped (Figure 3). The reduction in
amplitude could have reflected a dampening of individual
oscillators, and/or an inefficient synchronization between
oscillators. To discriminate between these possibilities, we
analysed temporal Bmal1-luc expression in individual cells
treated with or without 3 or 5mg/ml of a-amanitin, using the
Olympus LV 200 bioluminescence workstation, a highly
sensitive photon-counting microscope (see Materials and
methods). As demonstrated by the time-lapse video recording
provided in Supplementary data and at representative single-
cell bioluminescence profiles (Figure 4A, B (control panel)
and E), most of the recorded untreated cells (90%) exhibited
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Figure 3 NIH3T3 circadian oscillators are functional at significantly reduced RNA polymerase II-dependent transcription rates. (A) NIH3T3
Bmal1-luc cells (grown to confluence) were incubated for 16 h in the presence of 0–5mg/ml of a-amanitin. At time 0, cells were induced by
dexamethasone, a-amanitin was removed and bioluminescence was recorded for 172 consecutive hours (left panel). Increasing doses of
a-amanitin resulted in progressively shorter period lengths. The mean period lengths±s.d. determined in ‘n’ repetitions in five independent
experiments were 25.9±0.9, 25.5±0.3 and 23.6±1.1 h for 0, 1 and 3mg/ml of a-amanitin, respectively; n¼ 18; see middle panel. The
magnitudes (maximal photon counts) decreased with increasing a-amanitin concentrations (right panel). Using bilateral t-test for statistical
analysis, the following significance values were obtained for data sets from cells on 3 mg/ml of a-amanitin treatment compared with untreated
samples: for period length change P¼ 7105; for magnitude P¼ 0.01. (B) NIH3T3 Bmal1-luc cells were incubated for 5 h in the presence of
0–100 nM of actinomycin D. At time 0, cells were treated with dexamethasone, actinomycin D was washed away and bioluminescence was
recorded for 186 h (left panel). Increasing doses of actinomycin D resulted in progressively shorter period length: 25.4±0.7, 24.5±0.9,
23.5±0.5 and 23.3±0.7 h for 0, 20, 50 and 100 nM of actinomycin D, respectively; n¼ 5; see middle panel. The magnitudes were reduced by
the drug treatment (right panel). The following significance values were obtained for data sets from cells on 50 nM of actinomycin D treatment
compared with control: P¼ 0.001; for magnitude P¼ 0.018.
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Figure 4 Individual a-amanitin-treated fibroblasts contain functional oscillators and have shorter period length. NIH3T3 Bmal1-luc fibroblasts
(grown to confluence) were incubated for 16 h with DMEMþ 10% FCS containing 0, 3 or 5mg/ml of a-amanitin. At time 0, cells were
synchronized by dexamethasone and time-lapse photon-counting microscopy was performed for three consecutive days as described in
Materials and methods (see Supplementary movies 1–3, respectively). (A) Time-lapse microscopy of circadian Bmal1-luc expression in three
individual cells each for untreated cells and cells pretreated with 3 or 5mg/ml of a-amanitin. (B) Bioluminescence intensity profiles of six
representative cells for each condition after synchronization with dexamethasone. (C) Histogram of period length distribution from 50 cells
(control or 3 mg/ml a-amanitin) and 26 cells for 5 mg/ml a-amanitin. Period length was obtained from the best fit function as described in
Supplementary data. The mean period lengths were 26.8±2.7, 24.1±3.6 and 23.4±3.2 h, respectively, for 0, 3 and 5mg/ml a-amanitin.
(D) The signal intensity distribution (integrated pixels over the second peak) was calculated using the best fit function for 50 cells (control or
3 mg/ml a-amanitin) and 26 cells for 5mg/ml a-amanitin. Mean sum intensities were 78 834.2±33 394, 41 347±18 097 and 37 806±10130
pixelsh for 0, 3 and 5mg/ml a-amanitin, respectively. ANOVA analysis of data sets presented in (C, D) against each other yielded the
following values: P¼ 21010 for the period length values; P¼ 7107 for mean sum intensities. (E) Percentages of oscillating cells among
untreated cells (N¼ 60), cells pretreated with 3mg/ml of a-amanitin (N¼ 65) and 5 mg/ml of a-amanitin (N¼ 40).
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robust circadian oscillations. Here, 78% of cells pretreated
with 3mg/ml of a-amanitin also displayed rhythmic Bmal1-luc
expression, albeit with a 25% lower magnitude on average, in
comparison to untreated counterparts (Figure 4B (a-amanitin
3mg/ml panel) and 4E; Supplementary data). Here, 65% of
cells pretreated with 5mg/ml of a-amanitin still exhibited
circadian Bmal1-luc luminescence cycles, with 50% lower
magnitude in comparison to control (Figure 4B (a-amanitin
5mg/ml panel) and 4E; Supplementary data). For both period
length and signal sum intensity, the distribution was clearly
shifted towards lower values for a-amanitin-treated cells
versus untreated control cells, and the mean values were in
good agreement with our results obtained with cell popula-
tions (Figure 4C and D).
In conclusion, our single-cell recordings suggested that the
partial inhibition of transcription by a-amanitin did not arrest
cell-autonomous clocks, but rather dampened the magnitude
and shortened the period length. In addition, a-amanitin
treatment led to a wider distribution of period lengths. The
blunted amplitudes of a-amanitin-treated cells revealed by
population analysis were thus caused by smaller fraction of
rhythmic cells, a widened period length distribution and
reduced amplitude of individual cells.
Temperature and transcription compensation:
manifestations of the same underlying principle?
Circadian oscillators have long been known to be tempera-
ture-compensated for both poikilotherm and homoeotherm
organisms (Pittendrigh, 1954; Konopka et al, 1989). In fact,
those of mammalian fibroblasts exhibit even a temperature
‘overcompensation’, that is, they run faster at lower tempera-
tures (Izumo et al, 2003; Tsuchiya et al, 2003). In agreement
with the conclusions made by these authors, our biolumines-
cence recordings obtained with Bmal1-luc cells (Figure 5A)
and primary skin tail fibroblasts from mPer2Hluc mice
(Figure 6D) suggested a decrease in period length with
descending temperature. As reduced temperature and tran-
scription had similar effects on oscillator period length, we
examined whether the period shortening is additive in a-
amanitin-treated cells at reduced temperature. At 371C, the
drug affected circadian amplitude and period length as ex-
pected (Figure 5B). However, as depicted in Figure 5C, tran-
scription inhibition had only a small effect on period length in
cells incubated at 331C. Hence, transcription and temperature
compensation might be manifestations of similar oscillator
features (see Discussion).
Temperature and transcription compensation in mPer1
knockout cells
As described earlier, the per gene has a key function in
temperature compensation in Drosophila, and a mutation in
the dimerization domain (PAS) of per renders the Drosophila
oscillator temperature sensitive (Konopka et al, 1989). We
thus wished to examine the possible role of Per1 in tempera-
ture and transcription compensation. As Per2-deficient fibro-
blasts are arrhythmic at the population level (Brown et al,
2005) and displayed unstable rhythms of low amplitude or
were arrhythmic at the single-cell level (Liu et al, 2007), the
role of PER2 in these processes could not be assessed. Per1
knockout mice (Zheng et al, 2001) were crossed with
Per2Hluc knock-in reporter mice (Yoo et al, 2004). Per1
knockout primary fibroblasts were shown to exhibit about
3 h shorter circadian period in comparison to wild-type cells
(Pando et al, 2002; Brown et al, 2005). In keeping with these
observations, bioluminescence cycles produced by Per1KO/
Per2Hluc fibroblasts displayed 2–3 h shorter period as com-
pared with their Per1þ /þ/Per2Hluc counterparts.
Interestingly, however, the period length of these cells re-
mained similar when transcription rates were reduced by a
treatment with a-amanitin or actinomycin D (Figure 6A;
period lengths for control, a-amanitin- and actinomycin D-
treated cell lines are indicated on the graph). These
values were similar when extracted from the mathematical
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Figure 5 Transcription rates have mild effects on period length at
reduced temperatures. (A) Bmal1-luc fibroblasts were synchronized
with dexamethasone, placed into home-made precision incubators
at temperatures ranging from 31 to 411C, and bioluminescence cycles
were recorded during 168 h. Of note, the period length progressively
increases with elevated temperature. (B, C) Bioluminescence cycles
from untreated and a-amanitin-treated (3 mg/ml) Bmal1-luc fibro-
blasts were recorded for 92 h at 33 or at 371C. At 331C, the
a-amanitin-induced period shortening was less significant (23.21±
0.42 versus 23.96±0.54 h) than at 371C (23.52±0.82 versus 26.03
±0.54 h). The following P-values were obtained for data sets
compared with each other: period length from cells on 3mg/ml of
a-amanitin treatment compared with untreated samples at 371C (B)
P¼ 0.001 and at 331C (C) P¼ 0.12.
Transcription rates and circadian oscillators
C Dibner et al
The EMBO Journal VOL 28 | NO 2 | 2009 &2009 European Molecular Biology Organization128
derivatives of the raw data curves, in which the oscillations
are accentuated (Figure 6B). Unexpectedly, the amplitude—
which was found to be low in untreated Per1KO/Per2Hluc
cells (Brown et al, 2005; Liu et al, 2007)—became somewhat
more robust in actinomycin D-pretreated cells.
To characterize the oscillator properties of Per1KO/
Per2Hluc cells further, we assessed their bioluminescence
cycles at different temperatures. Remarkably, the period
length of these fibroblasts was about 1 hour shorter at higher
temperature within the examined 32–391C range (Figure 6C).
Our analysis thus suggested that the period of Per1KO cells
became slightly shorter at higher temperature, opposite from
the trend observed for their wild-type counterparts (see
Figure 6E for comparison of period length change as depicted
in Figure 6C and D). Hence, the temperature ‘overcompensa-
tion’ typical for fibroblast oscillators depended on Per1,
suggesting that this protein affects the mechanisms under-
lying both transcription and temperature compensation
in mammalian cells.
Period and amplitude behaviour in common circadian
oscillator models
To assess how our experimental findings compare with
mathematical models for circadian oscillators, we simulated
the period and the amplitude properties in two low-dimen-
sional models (Figure 7A and B; Supplementary Figure 4A
and B), and two higher dimensional kinetic models for the
mammalian oscillator (Figure 7C and D; Supplementary
Figure 4C and D). We hypothesized that transcription rates
were reduced uniformly by the drugs and thus introduced the
scale parameter r that rescales all mRNA synthesis rates. The
low-dimensional models implement two prototypical designs
for circadian oscillators, a delayed negative feedback loop
(Figure 7A), related to the Goodwin oscillator (Gonze and
Goldbeter, 2006), and a relaxation oscillator (Figure 7B) as
proposed by Barkai and Leibler (2000). The first shows a
period lengthening and amplitude increase with increasing
transcription rates, consistent with our experimental finding
(Figure 7A). A similar result was also found for another
implementation of a Goodwin-type model (Kurosawa and
Iwasa, 2005). In addition, the oscillatory regimen persists
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Figure 6 Per1 influences the response of fibroblast oscillators to
changes in global transcription rates and temperature. Skin tail
primary fibroblasts from Per1KO/Per2Hluc mice were pretreated for
16 h with 3mg/ml a-amanitin, or for 5 h with 50 nM actinomycin D,
and compared with untreated cells. Note that the mean period
lengths determined in five independent experiments (indicated in
the graph) did not change dramatically in response to these drugs,
but that the amplitude increased in actinomycin D-treated cells.
(B) Raw data from experiment (A) was subjected to linear regression
analysis: slopes indicated at Y axes were calculated for 542 time
points representing 9 h. (C) Bioluminescence cycles produced by
Per1KO/Per2Hluc mouse tail primary fibroblasts were recorded at
different temperatures as described in the legend of Figure 5. The
cells were oscillating with progressively shorter period at increasing
temperatures. (D) Per2Hluc mouse tail fibroblasts (immortalized
with an expression vector encoding SV40 virus large T antigen)
were grown to confluence, synchronized with dexamethasone,
placed into individual boxes preheated to temperatures varying
from 29 to 391C, and bioluminescence was recorded for 168 h.
Note that period length gets progressively longer with temperature
increase. (E) Period length from Per1KO cells (C) and their wild-
type counterparts (D) are plotted against temperature and have the
opposite trends. The following P-values were obtained for data sets
compared with each other: period length from Per1KO cells on 3mg/ml
of a-amanitin treatment compared with untreated Per1KO samples
(A, B) P¼ 0.2; for actinomycin D treatment P¼ 0.3; for period
length change at 321C in comparison to 391C for P1KO cells
P¼ 0.1 (C); for wt P¼ 0.03 (D), with the opposite trend.
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for reduction in transcription as large as 40%. Our imple-
mentation of a relaxation oscillator shows a relatively stable
period dependency in a range around r¼ 1, as expected for a
relaxation oscillator (Barkai and Leibler, 2000). However, the
period globally decreases with transcription rate (Figure 7B)
and seems thus unable to account for the experimental data
presented here. We now turn to more detailed mammalian
models. Even though the Leloup–Goldbeter model (Leloup
and Goldbeter, 2003) exhibits the right sign in the depen-
dency of period length on transcription, the transcription
range in which the model oscillates is much narrower than
observed experimentally (Figure 7C); thus, this model and its
parameters are in qualitative agreement with the data. Notice,
however, that alternate parameter sets for the same model
have been subsequently proposed (Leloup and Goldbeter,
2003), one of which exhibits a wider oscillatory range in
the function of the transcription rate. Similar to the relaxation
oscillator, the detailed Forger–Peskin model has an opposite
period dependency (Forger and Peskin, 2003). Moreover, the
half-hour period increase in the simulated case of Per1
knockout is inconsistent with experiments performed by us
and others (Zheng et al, 2001; Brown et al, 2005). These
simulations thus indicate limited predictability by some of the
commonly invoked kinetic models, and suggest that basic
architectures based on the Goodwin model come closest to
capturing qualitatively the period shortening observed on
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Figure 7 Period as a function of global transcription rates in common circadian oscillator models. The parameter r is a multiplicative factor
that controls all transcription rates, r¼ 1 corresponds to the published nominal parameter values. Two simple low-dimensional models (A, B)
and two more detailed models (C, D) are shown. (A) The three species Gonze-Goldbeter delayed negative feedback model with a messenger (m),
a cytoplasmic (C) and nuclear repressor (N) shows onset of oscillation at r¼ 0.43 (Hopf bifurcation). Oscillations are kept when
the transcription rate is raised by at least 20-fold. Period length initially rapidly increases with transcription, and then levels off at TB34 h.
The variation of the period with increased transcription r is positive around r¼ 1. The period lengthens with increasing r around r¼ 1.
(B) A minimal two species relaxation (hysteresis-based) oscillator given by the equations for an activator (A) and a repressor (R):
dA
dt
¼ s dAAþ f
A2
1þ A2
 eAR;
dR
dt
¼ kAR dRR
with parameters s¼ 0.064 [A]/h, dA¼ 0.32/h, f¼ 5.8 [A]/h, e¼ 1.6 [R]
1/h, k¼ 0.64 [A]1/h and dR¼ 0.15/h. Here, transcription and
translation processes are taken together. The model has an infinite period bifurcation near r¼ 0.27 and a Hopf bifurcation at r¼ 2.2. The
period shortens with increasing r around r¼ 1. (C) The 16-dimensional mammalian model by Leloup and Goldbeter. With its standard
parameters, this model has a very narrow range of oscillation around r¼ 1 within B10% of variation of the transcription rates in either
direction (Hopf bif urcations at r¼ 0.94 and r¼ 1.14). Furthermore, the model shows a cyclic fold in a narrow window around r¼ 1.1 with
coexistence of two stable (plain) and one unstable limit cycle (dashed line). The period lengthens with increasing r around r¼ 1. (D) The 74-
dimensional mammalian Forger–Peskin model. Here, the model has both Per1 and Per2 genes, and it is thus also possible to simulate the Per1
knockout phenotypes (dashed line). In contrast to the experimental data, the Per1 mutant oscillators display slightly longer periods.
Transcription can be reduced almost to zero while keeping oscillations. The period shortens with increasing r around r¼ 1. Oscillation
amplitudes for the same four models are shown in Supplementary Figure 4.
Transcription rates and circadian oscillators
C Dibner et al
The EMBO Journal VOL 28 | NO 2 | 2009 &2009 European Molecular Biology Organization130
reducing transcription rates. In fact, the Bmal1 loop in the
Leloup–Goldbeter model is very much reminiscent of the
three species Goodwin-type model.
Discussion
Fibroblast circadian oscillators are resilient to large
reductions in transcription rates
We demonstrate here that circadian oscillators keep running
in mouse fibroblasts in which overall Pol II-dependent tran-
scription rates are reduced up to three-fold. Inhibition of
transcription dampened the magnitudes and amplitudes of
clock gene expression cycles but did not eliminate them. The
observed resilience to reduced overall transcription rates
cannot be readily explained by a compensation of core
clock gene expression at the level of protein accumulation,
as in a-amanitin-treated cells, decreased Per2 and Cry2 mRNA
levels were accompanied by reduced PER2 and CRY2 protein
levels (Supplementary Figure 5). Hence, the negative feed-
back loop does not appear to be based on a stoichiometric
mechanism requiring absolute cellular threshold concentra-
tions of CRYs and PERs. Rather, these proteins may function
as cofactors in enzymatic processes, for example those in-
volved in regulating the circadian DNA affinity of BMAL1
and/or CLOCK/NPAS2, critical activators of Per and Cry
genes. BMAL1 and CLOCK and their Drosophila orthologues
CLK and CYC accumulate at similar levels throughout the
day, but display a rhythmic affinity for their E-box cognate
sequences both in vivo and in vitro (Ripperger and Schibler,
2006; Reinke et al, 2008; Taylor and Hardin, 2008).
In agreement with our statement of mammalian oscillator com-
pensation for large changes in transcription, Fan et al (2007)
have demonstrated that CRY1, CRY2 and BMAL1 protein
oscillation were not necessary for proper oscillator function
in mouse, Rat-1 and HEK293 cells. This report and our own
findings are not supportive of the current version of canonical
model of transcription–translation feedback loop.
In the circadian clock of the filamentous fungus
Neurospora crassa, the repressor protein FRQ serves as a
cofactor of protein kinases to modulate the cyclic DNA-
binding activity of the transcription factor complex WCC
(Brunner and Kaldi, 2008). A similar scenario may apply to
the control of CLOCK and BMAL1 activity by PER and CRY
proteins (Taylor and Hardin, 2008).
The circadian period shortening was observed irrespective
of whether actinomycin D or a-amanitin was used to reduce
overall transcription rates. We did observe, however, that
actinomycin D also affected the phase and the sharpness of
the first bioluminescence peak at the two lower concentra-
tions (Figure 3B). At these doses, the drug is expected to
completely suppress ribosomal Pol I-dependent transcription,
whereas only partially inhibiting Pol II-mediated transcrip-
tion. Conceivably, dexamethasone-induced immediate early
expression (e.g. that of PER1)—which is responsible for the
timing and duration of the first Bmal1-luc expression peak
and the synchronization of cellular oscillators—is altered in
cells with an increased mRNA/ribosome ratio. Alternatively,
the arrest of ribosomal RNA transcription by RNA Pol I may
release rate-limiting components required for immediate
early gene expression. RNA Pol I accounts for a very large
fraction of total nuclear RNA synthesis, and some regulatory
proteins (e.g. TBP, TFIIH) are shared by the RNA Pol I and II
transcription machineries (Eberhard et al, 1993; Iben et al,
2002).
The effect of reduced transcription rates on circadian gene
expression was also examined by single-cell bioluminescence
analysis (Supplementary movies 1–3). The period distribu-
tion of drug-treated cells was wider and shifted towards
shorter values when compared with untreated cells. The
broadening in period distributions is perfectly consistent
with increased intrinsic noise resulting from a reduced num-
ber of transcripts (Gonze and Goldbeter, 2006). On average,
the magnitudes of the bioluminescence cycles were reduced
in drug-treated cells, as expected. In keeping with our circa-
dian luciferase reporter data, the abundance of endogenous
clock transcripts and proteins oscillated with a lower ampli-
tude and magnitude under a-amanitin treatment. We noted,
however, that reduced transcription affected the amplitude of
Bmal1 and Rev-erba mRNA accumulation cycles somewhat
less than that of Per1, Per2 and Dbp accumulation cycles.
Hence, the transcription control mechanisms of some clock
genes might be somewhat more sensitive to this insult than
those of others. Interestingly, a correlation between reduced
amplitude and an increased sensitivity to phase-shifting
stimuli was recently observed in primary fibroblasts from a
large number of human subjects (Brown et al, 2008).
We also examined the effect of 5,6-dichloro-1-fl-D-riboben-
zimidazole (DRB) on circadian gene expression. This drug
inhibits transcription by preventing RPB1 phosphorylation
and thereby the escape of Pol II from promoters (Dubois et al,
1994). In contrast to a-amanitin and actinomycin D, DRB
actually lengthened the period by 3–3.5 h (data not shown).
However, DRB is also a potent inhibitor of casein kinase 1d/e
(CK1d/e) activity (Smith, 2002; Kim et al, 2008), and phos-
phorylation of circadian clock proteins by CK1d/e has a
crucial but complex function in period length determination
(Eide and Virshup, 2001; Lin et al, 2002). Although a muta-
tion comprising PER2 phosphorylation and a hypomorphic
mutation in CK1e resulted in period shortening (Lowrey et al,
2000; Toh et al, 2001; Xu et al, 2005; Vanselow et al, 2006),
the treatment of Rat-1 fibroblasts with the CKId/e-selective
inhibitor IC261 caused a period lengthening of circadian gene
expression (Eide et al, 2005). Thus, we cannot formally
exclude the possibility that the effects of actinomycin D or
a-amanitin on period length is caused by protein stability
changes or other, yet unknown post-translational mechan-
isms rather than by a general transcription reduction.
The notion that period length is determined by both
transcription and post-translation regulatory mechanisms
also emerged from studies on other systems. Kondo and
coworkers demonstrated that in cyanobacteria circadian pro-
tein phosphorylation can persist in the absence of transcrip-
tion and translation (Tomita et al, 2005) at some temperatures
and even succeeded in reconstituting a circadian oscillator in
vitro with only three clock proteins (KaiA, KaiB and KaiC)
and ATP (Nakajima et al, 2005). However, the same group
recently showed that in vivo circadian clock gene transcrip-
tion is required for a fully operative clock, and that period
length is determined by an interplay between KaiC phosphor-
ylation and cyclic gene expression (Kitayama et al, 2008).
Period length determination in the Drosophila circadian
clock—which shares many components with the mammalian
oscillator—also depends on an intricate cross-talk between
transcription and post-translation events. Thus, loss of function
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in DBT, the fruit fly homologue of CK1d/e, can either
shorten or lengthen the period, depending on the precise
location of the mutation (Muskus et al, 2007). Moreover,
when the transcription transactivation potential of the CLK–
CYC heterodimer is increased by fusing the strong acidic
activation domain of the Herpes virus protein VP16 to CYC,
the circadian period length considerably shortens (Kadener
et al, 2008). However, So and Rosbash (1997) also reported
on the importance of post-transcriptional regulation in
shaping the temporal per mRNA accumulation curve.
Conceivably, at reduced overall transcription rates this me-
chanism controlling circadian mRNA stability over-rides the
effect of transcription strength. This mechanism is actually
operative in flies carrying a gene lacking the normal promoter
(transgene 7.2) instead of the wild-type per allele. In these
flies, per transcription from spurious promoters is constitu-
tively low, and cyclic mRNA accumulation is driven by post-
transcriptional mechanisms. As circadian cell culture systems
are not yet available for the fruit fly, the impact of lowering
overall transcription rates on circadian gene expression could
not yet be examined in this species.
PER1 is involved in both temperature and transcription
compensation
In keeping with recently published reports (Izumo et al, 2003;
Tsuchiya et al, 2003), our data demonstrate that circadian
clocks of NIH3T3 mouse fibroblasts and primary mouse tail
fibroblasts are compensated—or rather overcompensated—
for temperature. In Drosophila, the Per protein has a key
function in temperature compensation, and perL mutant flies
loose temperature compensation and exhibit longer periods
at higher temperature (Konopka et al, 1989). Our results
suggest that Per proteins also have an important function in
the temperature control of circadian oscillators in mamma-
lian cells. Thus, Per1KO primary mouse tail fibroblasts are not
temperature-(over)compensated, and in contrast to their
wild-type counterparts oscillate with similar or even slightly
shorter periods at higher temperatures. Interestingly, the
effects of reduced Pol II transcription rates and decreased
temperature on period length shortening were not additive.
Likewise, Per1KO fibroblasts, normally oscillating with a 20-h
period, did not exhibit further period shortening upon
reduced transcription. These results would be compatible with
a model surmising that the same molecular mechanisms
underlie transcription and temperature compensation, and
that PER1 has a function in these mechanisms. It was
suggested for Drosophila that temperature-sensitive PER pro-
tein homodimerization, phosphorylation, protein degrada-
tion or alternative splicing of pre-mRNAs might account for
temperature compensation (Hong and Tyson, 1997; Leloup
and Goldbeter, 1997). Moreover, the role of PER in tempera-
ture compensation seems to be tightly linked to CRY proper
function (Kaushik et al, 2007). Similar mechanisms might be
responsible for temperature compensation in mammals, and
we are planning to address Per1 phosphorylation patterns
and Per–CRY complex formation at different temperatures.
Unexpectedly, weak oscillation amplitudes in Per1KO
mouse fibroblasts could be rendered more robust by an
actinomycin D treatment, suggesting the need of an optimal
balance between the levels of different clock components for
circadian oscillator function. A similar conclusion has been
reached in another study examining the cooperation between
PER and CRY proteins (Oster et al, 2002). Unexpectedly,
circadian rhythmicity and normal clock gene expression
patterns were restored in Per2 mutant mice by the inactiva-
tion of Cry2 (but not Cry1).
The impact of global transcription rates on period
length in mathematical models
Global changes in transcription and translation rates arise in
the body from variations in nutrition, growth condition or
temperature. The ability of circadian clocks to keep running
accurately despite significant variation in transcription rates
appears necessary for the oscillator to maintain synchrony
under different physiological conditions. The influence of
fluctuations on period length and period dispersion in simple
and complex models for the mammalian clock emphasized
the role of post-translational regulation on oscillator stability
(Rougemont and Naef, 2007). Here, we showed how low-
dimensional models for prototypical nonlinear oscillators
based on delayed negative feedback or relaxation oscillators
tolerate a large range in transcription rates for which self-
sustained oscillations are maintained, similar to what we
observed experimentally. Although both models show regi-
mens in which the period is rather insensitive to transcription
rates (Barkai and Leibler, 2000), their global period depen-
dence on transcription shows opposite signs, with Goodwin-
type models being in qualitative agreement with our experi-
ments. The more detailed mammalian models studied here
were only partially consistent with our data, suggesting that
the complexity of mammalian circadian clockworks is not yet
fully captured by commonly invoked models. Future analysis
will clarify the generality of our conclusions. Taken together,
our data are consistent with the scenario that both the
elimination of Per1 and the reduction of general transcription
destabilize the limit cycles by bringing the system closer to
the bifurcation boundaries. At the population level, low
circadian amplitudes were observed in both cases, and addi-
tional single-cell analysis will thus further clarify the under-
lying mechanisms.
Materials and methods
RNA synthesis measurement by uridine pulse assay
Uridine pulse assay was performed as described by Balajee et al
(1997). Briefly, NIH3T3 cells were pre-labeled with [14C]thymidine,
treated for 16 h with 0–5mg/ml of a-amanitin and pulse-labeled
with [3H]uridine for 60 min at the indicated time points. Radio-
activity incorporated into TCA-precipitated fraction was measured
by scintillation counting. Transcription rates were calculated as
the ratio of [3H]uridine incorporation per unit time divided by
[14C]thymidine incorporation into each sample, corresponding to
DNA content. Relative [3H]uridine incorporation corresponds to the
ratio of values obtained for untreated and drug-treated cells.
In vitro transcription run-on assay
Run-on transcription rates were determined in isolated nuclei under
conditions favouring Pol II-dependent transcription (Gariglio et al,
1981; Schmidt and Schibler, 1995). In vitro transcription rates were
calculated as [32P]UTP incorporation per minute per 106 cells.
Relative incorporation corresponds to the ratio of values obtained
for untreated and drug-treated cells.
RNA analysis by real-time quantitative PCR
Cells from triplicate plates were collected every 4 h by trypsiniza-
tion, rinsed with PBS, divided into two halves from each plate and
frozen at 701C. Total RNA was prepared from half of each plate
using Trizol reagent and used as a substrate for cDNA synthesis.
Genomic DNA was prepared from the other half of each plate using
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the NucleoSpin Tissue kit (Macherey–Nagel). RNA and genomic
DNA quantification by TaqMan real-time PCR was performed as
described by Heid et al (1996). Briefly, 1mg of total RNA was
reverse-transcribed using M-MLV Reverse Transcriptase (Invitro-
gen) and random hexamers. The resulting cDNA and genomic DNA
were PCR-amplified in an ABI PRISM 7700 Sequence Detection
System from PE-Applied Biosystems. Primers and probes are listed
in Supplementary Table 1.
Western blot experiments
Western blot experiments with whole-cell extracts were performed
with antibodies against RPB1 and U2AF65 (loading control).
Cell lines and constructs
NIH3T3 Bmal1-luc cells are described by Nagoshi et al (2004).
Mouse primary skin fibroblasts were prepared from mPer1/
mPer2Hluciferase or from mPer2Hluciferase tail tips by standard
procedure and grown in DMEM with 20% FCS. Where indicated,
cells were immortalized by transfection with Large T Antigen SV40
(pBABE-puro SV40LT; Addgene; plasmid number 13970) and
selected over several weeks.
Real-time bioluminescence monitoring
Cells were stimulated with either 50% horse serum or 100 nM
dexamethasone as described (Nagoshi et al, 2004). Cultures were
maintained at 371C in a light–tight incubator and bioluminescence
was monitored continuously using Hamamatsu photomultiplier
tube detector assemblies. Photon counts were integrated over 1-min
intervals.
Bioluminescence time-lapse microscopy and data analysis
NIH3T3 Bmal1-luc cells were plated in 35-mm glass bottom dishes
(WillCo-dish, type 3522; WillCo Wells BV). After treating the cells
with dexamethasone during 15 min, the medium was replaced by
2 ml phenol red-free DMEM supplemented with 10% FCS and 1 mM
luciferin. Bioluminescence imaging was performed on an Olympus
LV 200 bioluminescence workstation equipped with a  20
UPLSAPO objective (NA 0.75). Bioluminescence emission was
detected for several consecutive days using an EM CCD camera
(Image EM C9100-13; Hamamatsu, Japan) cooled to 901C using
exposure times of 30 min. The image series were analysed using the
ImageJ 1.32 software (National Institutes of Health, Bethesda, MD,
USA; as described in Supplementary data).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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